To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
1. Veno-occlusive disease (VOD) is a complication of Hematopoietic stem cell transplant (HSCT) with significant morbidity and mortality among transplant recipients
2. VOD involves damage to sinusoidal endothelial cells and hepatocytes leading to liver dysfunction.
3. Early recognition and diagnosis using the modified Seattle or Baltimore criteria is crucial.
4. Defibrotide is the only approved treatment for severe VOD and is effective when initiated early.
5. The prognosis of VOD depends on severity of the condition and the timeliness of intervention.
1. Engraftment syndrome (ES) is a common complication of HSCT.
2. ES is characterized by a constellation of symptoms, including fever, rash, and pulmonary infiltrates, which occur around the time of neutrophil recovery.
3. Prompt recognition and treatment with corticosteroids are essential to mitigate the cytokine inflammatory response.
4. The differential diagnosis of ES should consider infections and acute graft-versus-host disease (GVHD), requiring careful clinical assessment.
5. Distinguishing features of ES from GVHD include early time of presentation, fluid retention and pulmonary edema.
1. Hematopoietic cell transplants are becoming increasingly common and ED providers should remain vigilant for post-transplant complications.
2. These patients are at high risk for post-transplant emergencies due to their pre-existing comorbid conditions, toxicities from high-dose chemotherapy, prolonged immunosuppression, and opportunistic infections resulting from their immunocompromised state.
3.Hematopoietic cell transplant patients face significant risks for complications such as Graft-versus-host disease (GVHD), which further complicates their recovery and requires vigilant monitoring.
4. GVHD is a common and treatable post-transplant complication but must be recognized early to avoid complications.
5. Treatment of post-hematopoietic cell transplant complications should be performed in close collaboration with hematology/oncology, and often these complications result in hospitalization.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.